Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.

IF 3.1 2区 医学 Q2 CLINICAL NEUROLOGY
Journal of Neuro-Oncology Pub Date : 2025-11-01 Epub Date: 2025-07-24 DOI:10.1007/s11060-025-05151-5
Tomasz Pienkowski, Patrycja Mojsak, Tomasz Kowalczyk, Dominik Cysewski, Mikolaj Krupa, Robert Rutkowski, Zenon Mariak, Adrian Godlewski, Joanna Reszec, Marcin Moniuszko, Adam Kretowski, Tomasz Lyson, Michal Ciborowski
{"title":"Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.","authors":"Tomasz Pienkowski, Patrycja Mojsak, Tomasz Kowalczyk, Dominik Cysewski, Mikolaj Krupa, Robert Rutkowski, Zenon Mariak, Adrian Godlewski, Joanna Reszec, Marcin Moniuszko, Adam Kretowski, Tomasz Lyson, Michal Ciborowski","doi":"10.1007/s11060-025-05151-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Gliomas are highly heterogeneous central nervous system tumors that evolve through progressive molecular reprogramming. While cell proliferation and adhesion mechanisms are well-characterized, the contribution of vesicle trafficking to glioma progression remains underexplored. This study aimed to characterize proteomic changes across glioma grades.</p><p><strong>Methods: </strong>We performed untargeted, quantitative proteomic profiling of glioma tissues across WHO grades I-IV using a combination of Tandem Mass Tag (TMT)-11plex labeling and high-resolution liquid chromatography-mass spectrometry (LC-MS). Tissue samples were processed using filter-aided sample preparation (FASP) and analyzed using a µPAC reverse-phase HPLC system coupled to a high-resolution mass spectrometer. Protein identification and quantification were conducted through database searching and validated against stringent quality control criteria.</p><p><strong>Results: </strong>We identified over 4,400 proteins across samples, revealing dynamic, grade-specific shifts in vesicle trafficking. Grade II gliomas showed upregulation of exocytic proteins (e.g., synaptotagmin, syntaxin, clathrin) and suppression of dynamin, suggesting enhanced vesicular secretion. Grade III tumors exhibited the opposite trend-marked downregulation of exocytic components with concurrent activation of clathrin-mediated endocytosis. Grade IV gliomas displayed a hybrid profile, with partial reactivation of exocytic machinery alongside sustained endocytic activity, indicative of vesicular plasticity.</p><p><strong>Conclusion: </strong>This study highlights the synaptic vesicle cycle as a progressively remodeled pathway in glioma biology. Our findings suggest that vesicle trafficking is a critical, underrecognized feature of glioma pathogenesis and may represent a novel axis for therapeutic exploration.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"585-598"},"PeriodicalIF":3.1000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420692/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-05151-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Gliomas are highly heterogeneous central nervous system tumors that evolve through progressive molecular reprogramming. While cell proliferation and adhesion mechanisms are well-characterized, the contribution of vesicle trafficking to glioma progression remains underexplored. This study aimed to characterize proteomic changes across glioma grades.

Methods: We performed untargeted, quantitative proteomic profiling of glioma tissues across WHO grades I-IV using a combination of Tandem Mass Tag (TMT)-11plex labeling and high-resolution liquid chromatography-mass spectrometry (LC-MS). Tissue samples were processed using filter-aided sample preparation (FASP) and analyzed using a µPAC reverse-phase HPLC system coupled to a high-resolution mass spectrometer. Protein identification and quantification were conducted through database searching and validated against stringent quality control criteria.

Results: We identified over 4,400 proteins across samples, revealing dynamic, grade-specific shifts in vesicle trafficking. Grade II gliomas showed upregulation of exocytic proteins (e.g., synaptotagmin, syntaxin, clathrin) and suppression of dynamin, suggesting enhanced vesicular secretion. Grade III tumors exhibited the opposite trend-marked downregulation of exocytic components with concurrent activation of clathrin-mediated endocytosis. Grade IV gliomas displayed a hybrid profile, with partial reactivation of exocytic machinery alongside sustained endocytic activity, indicative of vesicular plasticity.

Conclusion: This study highlights the synaptic vesicle cycle as a progressively remodeled pathway in glioma biology. Our findings suggest that vesicle trafficking is a critical, underrecognized feature of glioma pathogenesis and may represent a novel axis for therapeutic exploration.

蛋白质组学分析揭示了胶质瘤等级间囊泡运输的动态调节。
目的:胶质瘤是一种高度异质性的中枢神经系统肿瘤,通过进行性分子重编程进化而来。虽然细胞增殖和粘附机制已被很好地表征,但囊泡运输对胶质瘤进展的贡献仍未得到充分探讨。本研究旨在表征胶质瘤等级之间的蛋白质组学变化。方法:我们使用串联质量标签(TMT)-11plex标记和高分辨率液相色谱-质谱联用(LC-MS)对WHO I-IV级胶质瘤组织进行了非靶向的定量蛋白质组学分析。组织样品采用过滤辅助样品制备(FASP)处理,并使用µPAC反相高效液相色谱系统耦合高分辨率质谱仪进行分析。通过数据库检索和严格的质量控制标准进行蛋白质鉴定和定量。结果:我们在样品中鉴定了超过4,400种蛋白质,揭示了囊泡运输的动态,年级特异性变化。II级胶质瘤表现为胞外蛋白(如synaptotagmin、syntaxin、clathrin)上调和动力蛋白抑制,提示囊泡分泌增强。III级肿瘤表现出相反的趋势——胞外成分显著下调,同时网格蛋白介导的内吞作用被激活。IV级胶质瘤表现出一种杂交特征,具有部分胞外机制的再激活和持续的内吞活性,表明具有囊泡可塑性。结论:本研究强调突触囊泡周期在胶质瘤生物学中是一个渐进式重塑的途径。我们的研究结果表明,囊泡运输是胶质瘤发病机制中一个关键的、未被认识的特征,可能代表着治疗探索的新方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信